ABOUT ADVARRA
Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted IRB and IBC review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster. For more information, visit advarra.com.
BROCHURES
- Advarra Connect
- Advarra Cloud
- GxP Auditing, Compliance, And Specialized Consulting
- IRB Solutions To Empower Better Research Programs
- GMP Auditing, Compliance, And Specialized Consulting
- Clinical Quality Assurance And Compliance Oversight
- Streamline Data Collection, Management, And Compliance
- A Clinical Command Center For Efficient, Compliant Research
- Solutions For Health Authority Inspection Readiness And Remediation
- IRB Services For Institutional Sites
- Meeting Compliance Without Compromise
- Advarra University And Training
- Global Consulting Powered By Relevant Experience
- Mitigate Risk With Research Billing Compliance Services
- Cosmetics Research And IRB Review
- Advarra eReg Integrations Overview
- Successful Clinical Research Staffing Solutions
- Support For Institutions
- Advarra Custom Learning Portals
- Elevate Your Research With Comprehensive Tools And Expertise
CONTACT INFORMATION
Advarra
6940 Columbia Gateway Drive, Suite 110
Columbia, MD 21046
UNITED STATES
Phone: 410.884.2900
FEATURED ARTICLES
-
Learn about strategies aimed to reduce protocol deviations and enhance compliance and quality. By implementing such measures, clinical trial teams can streamline operations and minimize the risk of regulatory issues.
-
Uncover several informative metrics which present themselves much sooner and allow research teams to take preventative action, versus costly reactive measures.
-
Delve into site and protocol violations to gain insights on how to assist sites in enhancing their compliance without adding undue burdens that could affect critical timelines.
-
By overcoming site challenges, discover how sponsors can enhance collaboration, improve trial efficiency, and ultimately accelerate the development of new treatments and therapies.
-
By recognizing and addressing the challenges associated with eSource integration, research facilities can fully harness its transformative potential, optimizing efficiency and reliability.
-
As much as eConsent helps staff, participants are also likely to prefer it over traditional paper methods. Explore the benefits of eConsent and some strategic steps sites can take right now to adopt the process.
-
Uncover how the DMS policy intends to promote transparency, collaboration, and the rapid transformation of research outcomes into tangible advancements for the betterment of human health.
-
Explore the details of a transformative partnership where a children's hospital was able to overcome coverage analysis and budget negotiation issues despite a significant staff turnover.
-
Uncover key survey findings gleaned from the perspectives of over 500 clinical researchers regarding technological trends and recommendations for enhancing the overall site experience.
-
Uncover how a pharmaceutical company and its strategic partners were able to provide oversight of key performance indicators relevant to the pharma's business model, which enabled escalation and remediation of any concerns.
-
Explore expectations set by the U.S. Food and Drug Administration (FDA) regarding the implementation of current Good Manufacturing Practices standards for investigational drugs.
-
Utilize this report to enhance the overall site experience during clinical trial operations, improve site experiences, expedite study initiation, and advance clinical development.
-
For clinical development entities, see how a well-executed CAPA system can function as a guide and steer the course toward continual enhancement while upholding regulatory adherence.
-
Look at the specific role DMCs play in overseeing research, and how IRBs rely on the independent DMC’s oversight of interim trial data to ensure an adequate safety monitoring plan is in place.